<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37006590</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study.</ArticleTitle><Pagination><StartPage>1055440</StartPage><MedlinePgn>1055440</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1055440</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1055440</ELocationID><Abstract><AbstractText>Psychological disturbances are frequent following COVID-19. However, there is not much information about whether pre-existing psychological disorders are associated with the severity and evolution of COVID-19. We aimed to explore the associations between regular psychotropic medication use (PM) before infection as a proxy for mood or anxiety disorders with COVID-19 recovery trajectories. We used data from the Predi-COVID study. We followed adults, tested positive for SARS-CoV-2 and collected demographics, clinical characteristics, comorbidities and daily symptoms 14 days after inclusion. We calculated a score based on 16 symptoms and modeled latent class trajectories. We performed polynomial logistic regression with PM as primary exposure and the different trajectories as outcome. We included 791 participants, 51% were men, and 5.3% reported regular PM before infection. We identified four trajectories characterizing recovery dynamics: "Almost asymptomatic," "Quick recovery," "Slow recovery," and "Persisting symptoms". With a fully adjusted model for age, sex, socioeconomic, lifestyle and comorbidity, we observed associations between PM with the risks of being in more severe trajectories than "Almost Asymptomatic": "Quick recovery" (relative risk (95% confidence intervals) 3.1 (2.7, 3.4), "Slow recovery" 5.2 (3.0, 9.2), and "Persisting symptoms"11.7 (6.9, 19.6) trajectories. We observed a gradient of risk between PM before the infection and the risk of slow or no recovery in the first 14&#x2009;days. These results suggest that a pre-existing psychological condition increases the risk of a poorer evolution of COVID-19 and may increase the risk of Long COVID. Our findings can help to personalize the care of people with COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Aguayo, Fischer, Elb&#xe9;ji, Linn, Ollert and Fagherazzi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aguayo</LastName><ForeName>Gloria A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Aur&#xe9;lie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elb&#xe9;ji</LastName><ForeName>Abir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linn</LastName><ForeName>Nyan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UNAIDS, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ollert</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allergy and Clinical Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagherazzi</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">cohort study (or longitudinal study)</Keyword><Keyword MajorTopicYN="N">depressive symptoms</Keyword><Keyword MajorTopicYN="N">latent class trajectory analyses</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">psychotropic medication</Keyword><Keyword MajorTopicYN="N">symptom score</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37006590</ArticleId><ArticleId IdType="pmc">PMC10062525</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1055440</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. (2020) 324:1723&#x2013;4. doi: 10.1001/jama.2020.19719, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodebaugh TL, Frumkin MR, Reiersen AM, Lenze EJ, Avidan MS, Miller JP, et al. . Acute Symptoms of Mild to Moderate COVID-19 are Highly Heterogeneous Across Individuals and Over Time. Open Forum Infectious Diseases. United States: Oxford University Press; (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989225</ArticleId><ArticleId IdType="pubmed">33796601</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Lee KA, Lochlainn MN, Varsavsky T, Murray B, Graham MS, et al. . Symptom clusters in COVID-19: a potential clinical prediction tool from the COVID symptom study app. Sci Adv. (2021) 7:eabd4177. doi: 10.1126/sciadv.abd4177, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd4177</ArticleId><ArticleId IdType="pmc">PMC7978420</ArticleId><ArticleId IdType="pubmed">33741586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Guo Y, et al. . Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of sars-cov-2 infection: retrospective cohort study. BMJ. (2022); 376. e068414. doi: 10.1136/bmj-2021-068414</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Benito Ballesteros A, Yeung SP, Liu R, Saha A, Curtis L, et al. . COVCOG 1: factors predicting physical, neurological and cognitive symptoms in long COVID in a community sample. A first publication from the COVID and cognition study. Front Aging Neurosci. (2022) 14:14. doi: 10.3389/fnagi.2022.804922</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804922</ArticleId><ArticleId IdType="pmc">PMC8968323</ArticleId><ArticleId IdType="pubmed">35370617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein AAM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. . Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. (2021) 15:1&#x2013;8. doi: 10.1186/s43168-020-00049-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuomo A, Amore M, Arezzo MF, De Filippis S, De Rose A, La Pia S, et al. . Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward. Ann General Psychiatry. (2022) 21:30. doi: 10.1186/s12991-022-00410-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12991-022-00410-5</ArticleId><ArticleId IdType="pmc">PMC9363263</ArticleId><ArticleId IdType="pubmed">35948983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagiolini A, Cuomo A, Frank E. COVID-19 diary from a psychiatry department in Italy. J Clin Psychiatry. (2020) 81:3909. doi: 10.4088/JCP.20com13357</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.20com13357</ArticleId><ArticleId IdType="pubmed">32237301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-W, Kang H-J, Jhon M, Ryu S, Lee J-Y, Kang S-J, et al. . Associations between CoViD-19 symptoms and psychological distress. Front Psych. (2021) 12:1401. doi: 10.3389/fpsyt.2021.721532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.721532</ArticleId><ArticleId IdType="pmc">PMC8415963</ArticleId><ArticleId IdType="pubmed">34484008</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye AY-K, Law JW-F, Tan LT-H, Pusparajah P, Ser H-L, Thurairajasingam S, et al. . Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Biology. (2022) 11:61. doi: 10.3390/biology11010061, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11010061</ArticleId><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayling K, Jia R, Coupland C, Chalder T, Massey A, Broadbent E, et al. . Psychological predictors of self-reported COVID-19 outcomes: results from a prospective cohort study. Ann Behav Med. (2022) 56:484&#x2013;97. doi: 10.1093/abm/kaab106, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abm/kaab106</ArticleId><ArticleId IdType="pmc">PMC8755370</ArticleId><ArticleId IdType="pubmed">34979556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ca&#xf1;as-Gonz&#xe1;lez B, Fern&#xe1;ndez-Nistal A, Ram&#xed;rez JM, Mart&#xed;nez-Fern&#xe1;ndez V. Influence of stress and depression on the immune system in patients evaluated in an anti-aging unit. Front Psychol. (1844) 11:1844. doi: 10.3389/fpsyg.2020.01844</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.01844</ArticleId><ArticleId IdType="pmc">PMC7417678</ArticleId><ArticleId IdType="pubmed">32849086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. (2021) 20:124&#x2013;30. doi: 10.1002/wps.20806, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20806</ArticleId><ArticleId IdType="pmc">PMC7675495</ArticleId><ArticleId IdType="pubmed">33026219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagherazzi G, Fischer A, Betsou F, Vaillant M, Ernens I, Masi S, et al. . Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study. BMJ Open. (2020) 10:e041834. doi: 10.1136/bmjopen-2020-041834, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041834</ArticleId><ArticleId IdType="pmc">PMC7684799</ArticleId><ArticleId IdType="pubmed">33234656</ArticleId></ArticleIdList></Reference><Reference><Citation>Buuren S, Groothuis-Oudshoorn K. MICE: multivariate imputation by chained equations in R. J Stat Softw. (2011) 45:1&#x2013;67. doi: 10.18637/jss.v045.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, Rubin DB. Fully conditional specification in multivariate imputation. J Stat Comput Simul. (2006) 76:1049&#x2013;64. doi: 10.1080/10629360600810434</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10629360600810434</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung T, Wickrama KA. An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass. (2008) 2:302&#x2013;17. doi: 10.1111/j.1751-9004.2007.00054.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-9004.2007.00054.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller BE, Bowen NK, Faubert SJ. Latent class analysis: a guide to best practice. J Black Psychol. (2020) 46:287&#x2013;311. doi: 10.1177/0095798420930932</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0095798420930932</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP, et al. . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. (2014) 12:1495&#x2013;9. doi: 10.1016/j.ijsu.2014.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrat F, Touvier M, Severi G, Meyer L, Jusot F, Lapidus N, et al. . Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study. BMC Infect Dis. (2021) 21:1&#x2013;13. doi: 10.1186/s12879-021-05864-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05864-8</ArticleId><ArticleId IdType="pmc">PMC7875161</ArticleId><ArticleId IdType="pubmed">33568097</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Gunning FM, McCoy TH, Perlis RH. Mood disorders and outcomes of COVID-19 hospitalizations. Am J Psychiatr. (2021) 178:541&#x2013;7. doi: 10.1176/appi.ajp.2020.20060842</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2020.20060842</ArticleId><ArticleId IdType="pubmed">33820425</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon H-L, Kwon JS, Park S-H, Shin J-Y. Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study. Br J Psychiatry. (2021) 218:344&#x2013;51. doi: 10.1192/bjp.2020.251, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2020.251</ArticleId><ArticleId IdType="pubmed">33407954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimi K, Neylan TC, Bertenthal D, Seal KH, O&#x2019;Donovan A. Association of Psychiatric Disorders with Incidence of SARS-CoV-2 breakthrough infection among vaccinated adults. JAMA Netw Open. (2022) 5:e227287-e. doi: 10.1001/jamanetworkopen.2022.7287, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.7287</ArticleId><ArticleId IdType="pmc">PMC9011123</ArticleId><ArticleId IdType="pubmed">35420660</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Ni S-Y, Yan W, Lu Q-D, Zhao Y-M, Xu Y-Y, et al. . Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action. EClinicalMedicine. (2021) 40:101111. doi: 10.1016/j.eclinm.2021.101111, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101111</ArticleId><ArticleId IdType="pmc">PMC8424080</ArticleId><ArticleId IdType="pubmed">34514362</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. (2021) 8:130&#x2013;40. doi: 10.1016/S2215-0366(20)30462-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn&#xfa;sd&#xf3;ttir I, Lovik A, Unnarsd&#xf3;ttir AB, McCartney D, Ask H, K&#xf5;iv K, et al. . Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. The lancet. Public Health. (2022) 7:e406&#x2013;16. doi: 10.1016/S2468-2667(22)00042-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce M, McManus S, Hope H, Hotopf M, Ford T, Hatch SL, et al. . Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data. Lancet Psychiatry. (2021) 8:610&#x2013;9. doi: 10.1016/S2215-0366(21)00151-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00151-6</ArticleId><ArticleId IdType="pmc">PMC9764381</ArticleId><ArticleId IdType="pubmed">33965057</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Cancela-Cilleruelo I, Moro-L&#xf3;pez-Menchero P, Rodr&#xed;guez-Jim&#xe9;nez J, Pellicer-Valero OJ. Trajectory curves of post-COVID anxiety/depressive symptoms and sleep quality in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP-CM multicenter study. Psychol Med (2022): 1&#x2013;2. doi: 10.1017/S003329172200006X</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770842</ArticleId><ArticleId IdType="pubmed">35000650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadian Khonsari N, Shafiee G, Zandifar A, Mohammad Poornami S, Ejtahed H-S, Asayesh H, et al. . Comparison of psychological symptoms between infected and non-infected COVID-19 health care workers. BMC Psychiatry. (2021) 21:1&#x2013;9. doi: 10.1186/s12888-021-03173-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-021-03173-7</ArticleId><ArticleId IdType="pmc">PMC7995388</ArticleId><ArticleId IdType="pubmed">33771122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Yang Y, Ren L, Shao Y, Tao W, Dai X-J. Preexisting mental disorders increase the risk of COVID-19 infection and associated mortality. Front Public Health. (2021) 9:1134. doi: 10.3389/fpubh.2021.684112</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.684112</ArticleId><ArticleId IdType="pmc">PMC8381336</ArticleId><ArticleId IdType="pubmed">34434913</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Gulbins E, Kornhuber J, Carpinteiro A, Abell&#xe1;n M, et al. . Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study. Transl Psychiatry. (2022) 12:90. doi: 10.1038/s41398-022-01804-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-01804-5</ArticleId><ArticleId IdType="pmc">PMC8892828</ArticleId><ArticleId IdType="pubmed">35241663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Villa G, De Lorenzo R, Querini PR, Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res. (2022) 155:112&#x2013;9. doi: 10.1016/j.jpsychires.2022.08.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.08.008</ArticleId><ArticleId IdType="pmc">PMC9391361</ArticleId><ArticleId IdType="pubmed">36029623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H, Gouraud C, Hulot J-S, Blanchard A, Ranque B, Lahlou-Lafor&#xea;t K, et al. . Do anxiety and depression predict persistent physical symptoms after a severe COVID-19 episode? A prospective study. Front Psych. (2021) 12:1875. doi: 10.3389/fpsyt.2021.757685</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.757685</ArticleId><ArticleId IdType="pmc">PMC8631493</ArticleId><ArticleId IdType="pubmed">34858230</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S, Zhang N, McPhaul MJ, Wu Z, Ghoshal AK, Erlich EC, et al. . Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19. JAMA Netw Open. (2021) 4:e2111398-e. doi: 10.1001/jamanetworkopen.2021.11398, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11398</ArticleId><ArticleId IdType="pmc">PMC8150664</ArticleId><ArticleId IdType="pubmed">34032853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. (2022) 36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Nami M, Mehrabi S, Kamali A-M, Kazemiha M, Carvalho J, Derman S, et al. . A new hypothesis on anxiety, sleep insufficiency, and viral infections; reciprocal links to consider in today's &#x201c;world vs. COVID-19&#x201d; endeavors. Front Psych. (2020) 11:585893. doi: 10.3389/fpsyt.2020.585893</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.585893</ArticleId><ArticleId IdType="pmc">PMC7674554</ArticleId><ArticleId IdType="pubmed">33250794</ArticleId></ArticleIdList></Reference><Reference><Citation>Rammal H, Bouayed J, Falla J, Boujedaini N, Soulimani R. The impact of high anxiety level on cellular and humoral immunity in mice. Neuroimmunomodulation. (2010) 17:1&#x2013;8. doi: 10.1159/000243079, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000243079</ArticleId><ArticleId IdType="pubmed">19816051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa Y, Ma M, Sawa A, Lane AP, Kamiya A. Olfactory impairment in psychiatric disorders: does nasal inflammation impact disease psychophysiology? Transl Psychiatry. (2022) 12:314. doi: 10.1038/s41398-022-02081-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-02081-y</ArticleId><ArticleId IdType="pmc">PMC9352903</ArticleId><ArticleId IdType="pubmed">35927242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Diallo AO, Dachy B, Le Bon SD, Maniaci A, Vaira LA, et al. . COVID-19: post-vaccine smell and taste disorders: report of 6 cases. Ear Nose Throat J. (2021):01455613211033125. doi: 10.1177/01455613211033125</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211033125</ArticleId><ArticleId IdType="pubmed">34467793</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins NJ, Cole SR, Harel O, Tchetgen Tchetgen EJ, Sun B, Mitchell EM, et al. . Principled approaches to missing data in epidemiologic studies. Am J Epidemiol. (2018) 187:568&#x2013;75. doi: 10.1093/aje/kwx348, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx348</ArticleId><ArticleId IdType="pmc">PMC5860376</ArticleId><ArticleId IdType="pubmed">29165572</ArticleId></ArticleIdList></Reference><Reference><Citation>Telenti A, Arvin A, Corey L, Corti D, Diamond MS, Garc&#xed;a-Sastre A, et al. . After the pandemic: perspectives on the future trajectory of COVID-19. Nature. (2021) 596:495&#x2013;504. doi: 10.1038/s41586-021-03792-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03792-w</ArticleId><ArticleId IdType="pubmed">34237771</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>